Evidence map›Paper›PMID 37462036›Full record

ArticleCirculation research2023

Brown Adipose Tissue and BMP3b Decrease Injury in Cardiac Ischemia-Reperfusion.

Íngrid Martí-Pàmies, Robrecht Thoonen, Michael Morley, Lauren Graves, Jesus Tamez, Alex Caplan, Kendra McDaid, Vincent Yao, Allyson Hindle, Robert E Gerszten and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Circulation research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Interplay between ischemia-reperfusion and metabolic reprogramming.Apoptosis : an international journal on programmed cell death · 2026
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Deciphering Uncoupling Proteins in Cellular Homeostasis and Metabolic Health.International journal of biological sciences · 2026
    Review
  11. Review
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 1 country.

Íngrid Martí-PàmiesCardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia (I.M.-P., M.M., L.G., J.T., A.C., K.M., L.L., M.S.-C.).ORCID 0000-0002-6870-2231
Robrecht ThoonenCardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia (I.M.-P., M.M., L.G., J.T., A.C., K.M., L.L., M.S.-C.).
Michael MorleyCardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia (I.M.-P., M.M., L.G., J.T., A.C., K.M., L.L., M.S.-C.).ORCID 0000-0002-0958-7376
Lauren GravesCardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia (I.M.-P., M.M., L.G., J.T., A.C., K.M., L.L., M.S.-C.).
Jesus TamezCardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia (I.M.-P., M.M., L.G., J.T., A.C., K.M., L.L., M.S.-C.).ORCID 0009-0005-6353-9606
Alex CaplanCardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia (I.M.-P., M.M., L.G., J.T., A.C., K.M., L.L., M.S.-C.).ORCID 0000-0002-9102-0079
Kendra McDaidCardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia (I.M.-P., M.M., L.G., J.T., A.C., K.M., L.L., M.S.-C.).
Vincent YaoCardiovascular Research Center, Massachusetts General Hospital, Boston (R.T., V.Y.).ORCID 0000-0002-1883-6434
Allyson HindleAnesthesia Center for Critical Care Research, Department of Anesthesia, Critical Care and Pain Medicine (A.H., E.S.B., D.B.B.), Massachusetts General Hospital Research Institute and Harvard Medical School, Boston.ORCID 0000-0002-1983-9573
Robert E GersztenDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA (R.E.G., L.A.F.).ORCID 0000-0002-6767-7687
Laurie A FarrellDivision of Cardiovascular Medicine, Beth Israel Deaconess Medical Center, Boston, MA (R.E.G., L.A.F.).
Li LiCardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia (I.M.-P., M.M., L.G., J.T., A.C., K.M., L.L., M.S.-C.).
Yu-Hua TsengSection on Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, MA (Y.-H.T., G.P.).
Gerson ProfetaSection on Integrative Physiology and Metabolism, Research Division, Joslin Diabetes Center, Harvard Medical School, Boston, MA (Y.-H.T., G.P.).ORCID 0000-0001-6394-2263
Emmanuel S BuysAnesthesia Center for Critical Care Research, Department of Anesthesia, Critical Care and Pain Medicine (A.H., E.S.B., D.B.B.), Massachusetts General Hospital Research Institute and Harvard Medical School, Boston.
Donald B BlochAnesthesia Center for Critical Care Research, Department of Anesthesia, Critical Care and Pain Medicine (A.H., E.S.B., D.B.B.), Massachusetts General Hospital Research Institute and Harvard Medical School, Boston.ORCID 0000-0002-6828-4754
Marielle Scherrer-CrosbieCardiovascular Institute, Perelman School of Medicine at the University of Pennsylvania, Philadelphia (I.M.-P., M.M., L.G., J.T., A.C., K.M., L.L., M.S.-C.).ORCID 0000-0001-6375-9266
Cardiovascular Institute of the South · USMassachusetts General Hospital · USBeth Israel Deaconess Medical Center · USJoslin Diabetes Center · USSt Vincent Hospital · US

Funding

SPECIAL ASSAY COREP30DK036836 · NIDDK · JOSLIN DIABETES CENTER · PI ROHIT N. KULKARNI · 1986 to 2026
$50.5M
Fibroblast Growth Factor and Energy MetabolismR01DK102898 · NIDDK · JOSLIN DIABETES CENTER · PI TSENG, YU-HUA · 2015 to 2024
$4.1M
Brown Adipose Tissue and CardioprotectionR01HL131613 · NHLBI · UNIVERSITY OF PENNSYLVANIA · PI SCHERRER-CROSBIE, MARIELLE · 2017 to 2020
$1.6M
NHLBI NIH HHS R01 HL131613NIDDK NIH HHS P30 DK036836NIDDK NIH HHS R01 DK102898
6 · The paper itself

Abstract

backgroundDespite advances in treatment, myocardial infarction (MI) is a leading cause of heart failure and death worldwide, with both ischemia and reperfusion (I/R) causing cardiac injury. A previous study using a mouse model of nonreperfused MI showed activation of brown adipose tissue (BAT). Recent studies showed that molecules secreted by BAT target the heart. We investigated whether BAT attenuates cardiac injury in I/R and sought to identify potential cardioprotective proteins secreted by BAT.

methodsMyocardial I/R surgery with or without BAT transplantation was performed in wild-type (WT) mice and in mice with impaired BAT function (uncoupling protein 1 [

resultsDysfunction of BAT in mice was associated with larger MI size after I/R; conversely, augmenting BAT by transplantation decreased MI size. We identified Bmp3b as a protein secreted by BAT after I/R. Compared with WT mice,

conclusionsThe results of this study suggest a cardioprotective role of BAT and BMP3b, a protein secreted by BAT, in a model of I/R injury. Interventions increasing BMP3b levels or targeting Smad 1/5 may represent novel therapeutic approaches to decrease myocardial damage in I/R injury.

Indexed as

Coronary Artery DiseaseGrowth Differentiation Factor 10Myocardial InfarctionMyocardial IschemiaMyocardial Reperfusion InjuryAdipose Tissue, BrownAnimalsHumansMiceMice, Inbred C57BLReperfusionGdf10 protein, mouseGrowth Differentiation Factor 10heart failuremicemyocardiumreperfusionuncoupling protein 1

Identifiers

PMID37462036
PMCPMC10528340
OpenAlexW4384625957

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.